The Chinese medicine Bu-Zhong-Yi-Qi-Tang inhibited proliferation of hepatoma cell lines by inducing apoptosis via G0/G1 arrest

Life Sciences

Volumn 69, Issue 13, 2001, Pages 1485-1496

  Kao, Shung Te ^a,b   Yeh, Chia Chou ^b   Hsieh, Chang Chi ^b   Yang, Mei Do ^a   Lee, Miau Rong ^b   Liu, Hsiao Sheng ^c   Lin, Jaung Geng ^b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Bu Zhong Yi Qi Tang; G0 G1 Arrest; Hepatoma; Hochu Ekki To

Indexed keywords

BROXURIDINE; BU ZHONG YI QI TANG; DNA FRAGMENT; GINSENOSIDE RB 1; GINSENOSIDE RG 1; GLYCYRRHIZIC ACID; SAIKOSAPONIN A; SAIKOSAPONIN C;

APOPTOSIS; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL STRAIN HEPG2; CHINESE MEDICINE; CONTROLLED STUDY; DNA SYNTHESIS; DOSE RESPONSE; DRUG EFFECT; HEPATOMA CELL; HUMAN; HUMAN CELL; IC 50;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL CYCLE; CELL DIVISION; CELL LINE; CULTURE MEDIA; DNA FRAGMENTATION; DNA, NEOPLASM; DRUGS, CHINESE HERBAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; LIVER NEOPLASMS, EXPERIMENTAL; RATS; TUMOR CELLS, CULTURED;

EID: 0035902794     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(01)01226-7     Document Type: Article

References (44)

1. Immunomodulation of Bu-Zhong-Yi-Qi-Tang on in vitro granulocyte colony-stimulating-factor and tumor necrosis factor-α production by peripheral blood mononuclear cells
2. Effect of TRH and buzhong yiqi tang on natural killer cell activity and endocrine in stress mice
3. Suppression of IgE production in mice treated with a traditional chinese medicine, bu-zhong-yi-qi-tang
4. Clinical and experimental observations of buzhong yiqi decoction in the treatment of chronic hepatitis B
5. Effects of buzhong yiqi decoction on the anticancer activity and toxicity induced by cyclophosphamide
6. Japanese modified traditional Chinese medicines as preventive drugs of the side effects induced by tumor necrosis factor and lipopolysaccharide
7. Prophylactic anti-tumor effect of Hochu-ekki-to (TJ41) by enhancing natural killer cell activity
8. Concomitant immunity against tumor development is enhanced by the oral administration of a kampo medicine, Hochu-ekki-to (TJ-41: Bu-Zhong-Yi-Qi-Tang)
9. Clinical and experiment observation of Chinese medicine in the treatment of middle and later stage HCC
10. Astragaloside from Egyptian Astragalus spino-sus Vahl
11. Inhibition of in vitro tumor cell invasion by ginsenoside Rg3
12. Antitumor effects of saikosaponins, baicalin and baicalein on human hepatoma cell lines
13. Anti-growth effects with components of Sho-saiko-to (TJ-9) on cultured human hepatoma cells
14. Saikosaponin A-induced cell death of a human hepatoma cell line (HuH-7): The significance of the 'sub-G1 peak' in a DNA histogram
15. Stimulation of host resistance against tumors by glycyrrhizin, an active component of licorice roots
16. Inhibition of mouse skin tumor-initiating activity of DMBA by chronic oral feeding of glycyrrhizin in drinking water
17. Apoptosis in liver disease
18. Apoptosis. Its significance in cancer and cancer therapy
19. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
20. A histochemical study of hypertrophy and ischaemic injury of rat liver with special reference to changes in lysosomes
21. Active cell death: Role in hepatocarcinogenesis and subtypes
22. Hepatitis B virus transgenic mice: Insights into the virus and the disease
23. Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters
24. Apoptosis-the mechanism of cell death in dimethy-nitrosamine-induced hepatotoxicity
25. In vitro apoptosis in the human hepatoma cell line induced by transforming growth factor beta 1
26. Rapid induction of apoptosis in rat liver by cycloheximide
27. Involvement of cyclin-dependent kinase activities in CD437-induced apoptosis
28. Prediction of relapse or survival after resection in human hepatomas by DNA flow cytometry
29. In vivo induction of apoptosis in immature thymocytes by staphylococcal enterotoxin B
30. Calcium-activated DNA fragmentation kills immature thymocytes
31. Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death
32. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation
33. Retinoic acid-induced apoptosis is prevented by serum albumin and enhanced by Lipiodol in human hepatoma Hep3B cells
34. The herbal medicine sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G0/G1 phase
35. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells
36. Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia
37. The effect of quercetin on cell cycle progression and growth of human gastric cancer cells
38. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II
39. Protective effect of total flavonoids of radix Astragali on mammalian cell damage caused by hydroxyl radical
40. Inhibition of adenosine 3′,5′-cyclic monophosphate phosphodiesterase by flavonoids from licorice roots and 4-arylcoumarins
41. Application of bromodeoxyuridine incorporation measurements to the determination of cell distribution within the S phase of the cell cycle
42. Flow cytometry and biochemical analysis of DNA degradation characteristic of two types of cell death
43. Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry
44. The herbal medicine sho-saiko-to inhibits the growth of malignant melanoma cells by upregulating Fas-mediated apoptosis and arresting cell cycle through downregulation of cyclin dependent kinases